மிஸ்டர்ர நெகிழ்வு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மிஸ்டர்ர நெகிழ்வு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மிஸ்டர்ர நெகிழ்வு Today - Breaking & Trending Today

Penumbra Inc (PEN) Q1 2021 Earnings Call Transcript

Operator
Good afternoon. My name is Katrina, and I will be your conference operator today. At this time, I would like to welcome everyone to Penumbra s First Quarter 2021 Conference Call. [Operator Instructions] Thank you.
I would like to introduce Mr. Stephen Dobson, Investor Relations for Penumbra. Mr. Dobson, you may begin your conference.
Stephen Dobson
Investor Relations
Thank you, operator, and thank you all for joining us on today s call to discuss Penumbra s earnings release for the first quarter of 2021. A copy of the press release and financial tables, which includes the GAAP to non-GAAP reconciliation, can be viewed under the Investors tab on our company website at www.penumbrainc.com. During the course of this conference call, the company will make forward-looking statements pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding our financial performance, commercialization, c ....

United States , Larry Biegelsen , Stephen Dobson , Maggie Yuen , Adam Elsesser , Bob Hopkins , Robbie Marcus Jpmorgan , Robbie Marcus , Brandon Vazquez William Blair , Asia Pacific , Margaret Kaczor , William Blair , Penumbra Inc , Bob Hopkins Bank , Genesis Medtech Group , Society Of Cardiovascular Angiography , Wells Fargo , First Quarter , Investor Relations , Safe Harbor , Private Securities Litigation Reform Act , Chief Financial Officer , Jason Mills , Executive Vice President , Chief Executive , Extra Flex ,

Penumbra, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results

(NYSE:
PEN), a global healthcare company focused on innovative therapies, today reported financial results for the fourth quarter and full year ended December 31, 2020.
Financial Highlights:
Revenue of $166.9 million for the fourth quarter of 2020, an increase of 14.9% compared to the fourth quarter of 2019. Excluding the impact of the voluntary recall (a non-GAAP measure)
1, revenue of $172.7 million for the fourth quarter of 2020, an increase of 18.9% compared to the same quarterly period a year ago or an increase of 17.7% in constant currency (a non-GAAP measure)
1. US revenue of $116.8 million for the fourth quarter of 2020 was 21.6% above the same period a year ago.
Revenue of $560.4 million ....

United States , Penumbra Inc , Exchange Commission , Prnewswire Penumbra Inc , Conference Call , Extra Flex , Annual Report , Consolidated Statements , Months Ended December , Ended December , Gross Profit , Operating Expenses , Revenue Change , Geographic Regions , Product Categories , ஒன்றுபட்டது மாநிலங்களில் , பரிமாற்றம் தரகு , மாநாடு அழைப்பு , மிஸ்டர்ர நெகிழ்வு , ஆண்டு அறிக்கை , தொகுக்கப்பட்டு அறிக்கைகள் , மொத்த ப்ராஃபிட் , இயங்குகிறது செலவுகள் , வருவாய் மாற்றம் , புவியியல் பகுதிகள் , ப்ராடக்ட் பிரிவுகள் ,

Penumbra, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results

Penumbra, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Penumbra Inc , Exchange Commission , Prnewswire Penumbra Inc , Conference Call , Extra Flex , Annual Report , Consolidated Statements , Months Ended December , Ended December , Gross Profit , Operating Expenses , Revenue Change , Geographic Regions , Product Categories , ஒன்றுபட்டது மாநிலங்களில் , பரிமாற்றம் தரகு , மாநாடு அழைப்பு , மிஸ்டர்ர நெகிழ்வு , ஆண்டு அறிக்கை , தொகுக்கப்பட்டு அறிக்கைகள் , மொத்த ப்ராஃபிட் , இயங்குகிறது செலவுகள் , வருவாய் மாற்றம் , புவியியல் பகுதிகள் , ப்ராடக்ட் பிரிவுகள் ,

The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal

The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal
Benzinga
12/16/2020
© Provided by Benzinga
Popular Searches
Anchiano Therapeutics Ltd – ADR (NASDAQ: ANCN) (announced a reverse merger with Chemomab)
Arvinas Inc (NASDAQ: ARVN)
Bioanalytical Systems, Inc. (NASDAQ: BASI)
BioCardia Inc (NASDAQ: BCDA)
BioTelemetry Inc (NASDAQ: BEAT)
Frequency Therapeutics Inc (NASDAQ: FREQ)
Globus Medical Inc (NYSE: GMED)
Inhibrx Inc (NASDAQ: INBX)
PRA Health Sciences Inc (NASDAQ: PRAH)
Prevail Therapeutics Inc (NASDAQ: PRVL) (announced a deal to be bought by
Eli Lilly And Co (NYSE: LLY))
Sesen Bio Inc (NASDAQ: SESN)
Solid Biosciences Inc (NASDAQ: SLDB) ....

Saudi Arabia , San Diego , United States , Switzerland General , Barry Greene , Jeff Jonas , Fosun Pharma , Elizabeth Barrett , Eli Lilly And Co , Biotelemetry Inc , Sio Gene Therapies Inc , Merck Co Inc , Mannkind Corporation , Frequency Therapeutics Inc , Pfizer Inc , Therapeutics Inc , Springworks Therapeutics Inc , Inmed Pharmaceuticals Inc , Aurinia Pharmaceuticals Inc , Abcellera Biologics Inc , Inhibrx Inc , Urogen Pharma Ltd , Corcept Therapeutics Incorporated , Phathom Pharmaceuticals Inc , Solid Biosciences Inc , Xencor Inc ,

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABCL) - The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABCL) - The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Saudi Arabia , San Diego , United States , Switzerland General , Barry Greene , Jeff Jonas , Fosun Pharma , Elizabeth Barrett , Aptose Biosciences Inc , Alnylam Pharmaceuticals Inc , Gilead Sciences Inc , Sio Gene Therapies Inc , Merck Co Inc , Vivos Therapeutics Inc , Pfizer Inc , Therapeutics Inc , Bioatla Inc , Inmed Pharmaceuticals Inc , Olema Pharmaceuticals Inc , Penumbra Inc , Aurinia Pharmaceuticals Inc , Abcellera Biologics Inc , Renal Drugs Advisory Committee , Urogen Pharma Ltd , Phathom Pharmaceuticals Inc , Lonza Ltd ,